You are here: Industry Insights > trial

News List

Recent Updates on the Guidelines to Clinical Trials through Innovations Shruti Talashi
January 15, 2025
The CDER Center for Clinical Trials Innovation (C3TI) was recently created by the FDA's Center for Drug Evaluation and Research (CDER) to facilitate and expand novel approaches to clinical trials intended to increase the effectiveness of drug development.
Decentralising research: Virtual clinical trials Suzanne Elvidge
May 14, 2024
Clinical trials are vital as the basis of developing safe and effective drugs, but they can be slow and expensive.
Clinical Research Organization's (CROs) using Artificial Intelligence (AI) tools in restructuring the clinical trials Shruti Talashi
April 11, 2024
Healthcare is embracing AI for better diagnosis, drug development, and patient care.
Understanding clinical trials in approval of novel medication into the health market Shruti Talashi
December 01, 2023
The first step in creating a new medication is to gain as much knowledge as you can about the illness or condition. Basic research offers hints about prospective treatment approaches for illnesses, including addressing their symptoms or underlying causes.
Key progress has been achieved in many clinical trials of Abexinostat. Jianghuzhiyuan/PharmaSources
June 27, 2023
How much progress has been made in the research and development of HDAC inhibitor?
Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production PharmaSources
May 15, 2023
Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic media supplier for industrial scale production
With the BGB-16673 Clinical Trials of BeiGene Launched, PROTAC Leads a Brand New Trend of Global Competition PharmaSources/Wanghong
March 21, 2022
On February 28, BGB-16673, a BTK-targeted PROTAC drug of BeiGene, was launched for clinical trials for the first time in China.
Human trial data of oral small molecule PD-1/PD-L1 inhibitors were first released PharmaSources/Xiaoyaowan
December 02, 2021
Recently, Incyte of the United States reported the Phase I clinical data of oral small molecule PD-L1 inhibitor INCB086550 in Journal for ImmunoTherapy of Cancer.
Continuous Manufacturing Part 2: Industrial Adoption of Continuous Pharmaceutical Manufacturing Deepak Hegde
May 10, 2021
This article, which is Part 2 of the series on continuous manufacturing focuses on the uptake of continuous manufacturing by the pharmaceutical industry for both API and drug products, scaleup to pilot scale and successes in commercialization.
New Track: Japanese Digital Therapeutics for Hypertension Achieves Success in Phase III Clinical Trial PharmaSources/Xiaoyaowan
April 07, 2021
The Japanese company CureApp has recently announced the results of a Phase III multicenter randomized controlled clinical trial of their digital therapeutics for hypertension, which was jointly researched by CureApp and a team led ...